Amit Sharma

Amit Sharma

Company: Alexion Pharmaceuticals

Job title: Vice President & Head Of Clinical Development & Global Therapeutic Area Nephrology & Hematology


Repositioning AKI at the Forefront of R&D: Targeting Complex Pathophysiology, Overcoming Heterogeneity & Enhancing Return on Investment 11:00 am

The heterogeneity across phenotypic subtypes has made AKI significantly difficult to study, therefore making progress of new specific treatments and disease management rather stagnant in recent years. From balancing the need for AKI resolution while minimizing long-term kidney damage, to addressing AKI subtypes with medical interventions that target specific underlying causes, tackle key questions with…Read more

day: Pre-Conference Workshop Day

Minimizing Patient Burden & Expanding Recruitment Efforts to Promote Diversity in CKD Trials 8:30 am

Gaining a deeper comprehension of the factors contributing to the underrepresentation of minorities in CKD studies Exploring what can be done, from leveraging social media to collaborating with advocacy groups, to revolutionize recruitment strategies Evaluating what is being done on a site, study and global level to reduce patient burden and encourage participationRead more

day: Conference Day 2

Clinical Progress in Regenerative Medicine: Striving Towards a One-Dose Cure for CKD
10:25 am

Read more

day: Day 2 Track 2 AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.